ViroCarb is a preclinical antiviral company founded and managed by an experienced team involved in world-leading research, with management experience and expertise in drug discovery, development and commercialization of small molecule therapeutics. We have assembled a cohesive and innovative group of collaborators and scientific advisors, world-class medicinal chemists, molecular pathologists, and leaders in legal and business development.
